Vedolizumab Shows Long-Term Safety, Efficacy in IBD Vedolizumab Shows Long-Term Safety, Efficacy in IBD

The gut-selective alpha4beta7 integrin antibody vedolizumab is safe and effective for long-term use in patients with inflammatory bowel disease.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news